Comprehensive multiple risk factor control in cancer survivors to mitigate heart failure risk: insights from a prospective cohort study - Report - MDSpire

Comprehensive multiple risk factor control in cancer survivors to mitigate heart failure risk: insights from a prospective cohort study

  • By

  • Yang-Wei Cai

  • Jing-Wei Gao

  • Mao-Xiong Wu

  • Ze-Gui Huang

  • Guang-Hong Liao

  • Chuan-Rui Zeng

  • Pin-Ming Liu

  • Yang-Xin Chen

  • Jing-Feng Wang

  • Hai-Feng Zhang

  • November 13, 2025

  • 0 min

Share

Holistic Management of Risk Factors Reduces Heart Failure in Cancer Survivors

Overview

This prospective cohort study of 14,466 cancer survivors found that comprehensive control of multiple modifiable risk factors significantly reduces the incidence of heart failure (HF). Controlling at least five risk factors lowered HF risk by 24%, aligning cancer survivors' HF risk with matched non-cancer controls.

Background

Cancer survivors face an elevated risk of cardiovascular disease, particularly heart failure, due to cardiotoxic cancer treatments and shared risk factors such as hypertension, diabetes, obesity, and smoking. Advances in cancer therapy have increased survivorship, highlighting the importance of preventing long-term cardiac complications. Prior research has linked risk factor control to reduced HF risk in other populations, but its impact specifically in cancer survivors was previously unclear.

Data Highlights

GroupParticipantsHeart Failure CasesMedian Follow-up (years)Hazard Ratio per Additional Controlled Risk Factor (95% CI)HR for ≥5 Risk Factors Controlled vs Lowest Control (95% CI)
Cancer Survivors14,46657212.540.88 (0.81–0.96)0.76 (0.61–0.95)
Matched Controls (No Cancer)57,8641,85112.54

Key Findings

  • Each additional controlled modifiable risk factor was associated with a 12% reduction in heart failure risk among cancer survivors (HR 0.88, 95% CI 0.81–0.96).
  • Joint control of at least five risk factors resulted in a 24% lower HF risk compared to the lowest risk factor control group (HR 0.76, 95% CI 0.61–0.95).
  • Cancer survivors with optimal risk factor control had a heart failure risk comparable to matched non-cancer controls.
  • Leading risk factors contributing to HF risk in cancer survivors included cancer type, chemotherapy exposure, physical inactivity, smoking, and elevated body mass index.
  • The study utilized a large, well-characterized UK Biobank cohort with long-term follow-up (median 12.54 years) and rigorous matching methodology.

Clinical Implications

Comprehensive management of modifiable risk factors such as blood pressure, BMI, lipid levels, glycemic control, renal function, smoking cessation, physical activity, and diet quality is crucial in reducing heart failure risk among cancer survivors. Clinicians should prioritize holistic cardiovascular risk assessment and intervention in this population to mitigate long-term cardiac morbidity. Achieving control of at least five risk factors may normalize heart failure risk to levels seen in individuals without cancer history.

Conclusion

This study demonstrates that holistic control of multiple cardiovascular risk factors significantly lowers heart failure incidence in cancer survivors, underscoring the importance of integrated cardio-oncology care to improve long-term outcomes.

References

  1. UK Biobank Study 2024 -- Holistic Management of Multiple Risk Factors in Cancer Survivors to Reduce Heart Failure Incidence

Original Source(s)

Related Content